Immunosuppression Outweighs Clinical AEIOU Heuristics in Predicting Disease Progression of Merkel Cell Carcinoma: A Retrospective Cohort Study
Laetitia S Chiarella, Entela Kupina, Maximilian Kückelhaus, Tobias Hirsch, Hans-Joachim Schulze, Jan-Dirk Raguse, Sascha Wellenbrock · 2026
Read Immunosuppression Outweighs Clinical AEIOU Heuristics in Predicting Disease Progression of Merkel Cell Carcinoma: A Retrospective Cohort Study by Laetitia S Chiarella, Entela Kupina, Maximilian Kückelhaus, Tobias Hirsch, Hans-Joachim Schulze, Jan-Dirk Raguse, Sascha Wellenbrock (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13464361.txt.
Description
Merkel cell carcinoma (MCC)is a rare but aggressive cutaneous malignancy with increasing incidence and poor prognosis. Host immune status is a key determinant of MCCmerkel cell carcinoma development and outcome. While the AEIOU criteria are widely used to facilitate clinical recognition, their value for prognostic assessment remains unclear.
Catalog record
| CREATOR | Laetitia S Chiarella, Entela Kupina, Maximilian Kückelhaus, Tobias Hirsch, Hans-Joachim Schulze, Jan-Dirk Raguse, Sascha Wellenbrock |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |